UNSPSC 51282139: Sulbenicillin sodium

This classification denotes a penicillin antibiotic with the molecular structure C16H16N2O7S2.2NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 29SO9LIM1Q chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenyl-2-sulfoacetyl)amino)-, sodium salt (1:2), (2s,5r,6r)-, but more commonly known as sulbenicillin sodium, which bears US NIH Compound Identifier 443984.

UNSPSC 51282139 Sulbenicillin sodium is a Commodity code, yet the recent state and local opportunities posted under this code show little direct relevance to the code's nominal pharmaceutical ingredient scope. The four opportunities identified span naloxone and drug deactivation systems procurement (Seminole County, Florida), a Texas HHS exploratory market-intelligence RFI on direct-to-manufacturer prescription programs, Tampa Fire Department medical and first aid supplies, and a Minnesota multistate cooperative purchasing agreement for generic multi-source pharmaceuticals and OTC products. None of these solicitations explicitly names sulbenicillin sodium or beta-lactam antibiotic compounds as a line item or primary procurement focus, suggesting either broad tagging of pharmaceutical-adjacent work to this code or a mismatch between the code classification and actual procurement activity. State and local issuing bodies using this code include county health departments, state health and human services agencies, municipal fire departments, and multistate cooperative purchasing alliances. The geographic spread includes Florida, Texas, Minnesota, and Oregon through the MMCAP cooperative purchasing vehicle.

The recent opportunities show healthcare systems, emergency services, and pharmacy benefit program administrators acquiring finished pharmaceutical products, medical supplies, and prescription-fulfillment services rather than raw pharmaceutical ingredients or active pharmaceutical ingredients like sulbenicillin sodium. Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023) seeks finished products for quarterly delivery; Tampa's ITB for medical and first aid supplies (due March 13, 2026, estimated $700,000.00) targets fire rescue consumables with a Small Local Business Enterprise set-aside and 5 percent bid discount; Minnesota MMCAP's RFP for generic pharmaceuticals and OTC products (due March 26, 2026) establishes multi-vendor agreements through authorized wholesalers for state and local government facilities; and Texas HHS's April 2026 RFI explores direct-to-manufacturer contracting models for pharmacy benefit programs. The mismatch between the code's chemical-compound specificity and the actual pharmaceutical procurement activity suggests this code may see limited relevant state and local solicitation volume aligned with its intended scope.